Adaptimmune Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Restructuring programme (Tables)

Restructuring programme (Tables)

12 Months Ended

Dec. 31, 2022

Restructuring programme

Schedule of movement in the restructuring provision


					One-time
		Contractual			employee			Total
		termination			termination			restructuring
		benefits			benefits			provision
Provision at January 1, 2022		$	—		$	—		$	—
Costs incurred and charged to General and administrative expenses			1,171			1,114			2,285
Provision at December 31, 2022		$	1,171		$	1,114		$	2,285

Schedule of amounts expected to be incurred in relation to the redundancy programme.


					One-time
		Contractual			employee			Total
		termination			termination			restructuring
		benefits			benefits			costs
Amount incurred in the year ended, and cumulative amount incurred to, December 31, 2022		$	1,171		$	1,114		$	2,285
Remaining amount expected to be incurred in future periods			—			947			947
Total amount expected to be incurred		$	1,171		$	2,061		$	3,232